Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec 1;94(7):926-927.
doi: 10.1002/ccd.28605.

Examining the Role of Diabetes Mellitus in ST-elevation Myocardial Infarction

Affiliations
Editorial

Examining the Role of Diabetes Mellitus in ST-elevation Myocardial Infarction

Rishi Chandiramani et al. Catheter Cardiovasc Interv. .

Comment on

Similar articles

See all similar articles

References

REFERENCES

    1. Control CfD, Prevention. National diabetes statistics report. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017:2017.
    1. Sabate M, Cequier A, Iñiguez A, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet. 2012;380(9852):1482-1490.
    1. Sabaté M, Brugaletta S, Cequier A, et al. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial. Lancet. 2016;387(10016):357-366.
    1. Iijima R, Byrne RA, Dibra A, et al. Drug-eluting stents versus bare-metal stents in diabetic patients with st-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from 7 randomized trials. Rev Esp Cardiol (Engl Ed). 2009;62(4):354-364.
    1. Baber U. The challenge of diabetes mellitus in the contemporary percutaneous coronary intervention era: are we making progress? J Am Coll Cardiol Interv. 2018;11(24):2477-2479. doi: 10.1016/j.jcin.2018.10.027.
Feedback